Market Capitalization (Millions $) |
203,489 |
Shares
Outstanding (Millions) |
2,092 |
Employees |
110,000 |
Revenues (TTM) (Millions $) |
46,660 |
Net Income (TTM) (Millions $) |
14,854 |
Cash Flow (TTM) (Millions $) |
7,517 |
Capital Exp. (TTM) (Millions $) |
1,060 |
Novartis Ag
Novartis AG is a Swiss multinational pharmaceutical company that specializes in developing and producing pharmaceutical products, generic drugs, vaccines, and medical devices. Novartis was formed in 1996 following the merger of two pharmaceutical companies e Ciba-Geigy and Sandoz. The company is headquartered in Basel, Switzerland, and operates in over 180 countries worldwide.
Novartis has a diversified product portfolio, which includes prescription drugs, over-the-counter (OTC) products, and animal health products. The company has a strong focus on research and development (R&D), with significant investments in clinical trials and new drug development. Novartis has over 65,000 employees globally, with roughly half of them working in research and development.
The company's operations are divided into three major business segments e Innovative Medicines, Sandoz, and Alcon. The Innovative Medicines business segment focuses on discovering, developing, and marketing innovative drugs for various therapeutic areas such as cardiovascular, neuroscience, immunology, and oncology. Sandoz is responsible for manufacturing and distributing generic drugs and biosimilars. Alcon, which was acquired by Novartis in 2011, produces eye care products such as contact lenses, eye drops, and surgical instruments.
Novartis has a strong global presence, with significant market share in Europe, Asia, and North America. The company reinvests a significant portion of its profits into R&D to maintain its position as a leading pharmaceutical company. Its commitment to R&D has resulted in several groundbreaking products, including cancer treatments, gene therapies, and cell-based therapies.
Novartis also has a strong sustainability and corporate social responsibility (CSR) strategy. The company is committed to reducing its environmental impact, improving access to healthcare, and supporting communities in need. It has established various partnerships with healthcare organizations, academic institutions, and government agencies to advance its CSR initiatives.
In conclusion, Novartis AG is a leading pharmaceutical company with a diversified product portfolio, a strong R&D focus, a global presence, and a commitment to sustainability and CSR. Its innovative medicines and products have improved the lives of millions of people worldwide.
Company Address: Lichtstrasse 35 Basel 4056
Company Phone Number: 324-1111 Stock Exchange / Ticker: NYSE NVS
|